[Congressional Record Volume 169, Number 120 (Thursday, July 13, 2023)]
[Senate]
[Page S2524]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SA 327. Ms. WARREN submitted an amendment intended to be proposed by
her to the bill S. 2226, to authorize appropriations for fiscal year
2024 for military activities of the Department of Defense, for military
construction, and for defense activities of the Department of Energy,
to prescribe military personnel strengths for such fiscal year, and for
other purposes; which was ordered to lie on the table; as follows:
At the appropriate place in title VII, insert the
following:
SEC. 7__. COMPTROLLER GENERAL STUDY ON BIOMEDICAL RESEARCH
AND DEVELOPMENT FUNDED BY DEPARTMENT OF
DEFENSE.
(a) Study.--The Comptroller General of the United States
shall conduct a study on the management by the Department of
Defense of biomedical research and development funded by the
Department, including a review of--
(1) patents for drugs approved by the Food and Drug
Administration that were supported with intramural or
extramural funding from the Department;
(2) requirements of the Department for how grant
recipients, contractors, and labs of the Department should
disclose support by the Department in patents generated with
funding from the Department; and
(3) the data systems of the Department for cataloging
information about patents generated with funding from the
Department.
(b) Briefing.--Not later than March 31, 2024, the
Comptroller General shall brief the Committees on Armed
Services of the Senate and the House of Representatives on
the study conducted under subsection (a).
(c) Report.--Not later than one year after the date of the
enactment of this Act, the Comptroller General shall submit
to the Committees on Armed Services of the Senate and the
House of Representatives a report on the study conducted
under subsection (a).
______